HempNewsBreaks – Hemptown USA Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition

Company: Hemptown USA
Category: Stock Spotlights

Hemptown USA recently announced the acquisition of assets that consist of the FDA-licensed, cGMP-certified operating nutraceutical business of the Kirkman Group (http://cnw.fm/an42G).  The Kirkman Group’s fully operational 25,000-square-foot nutraceutical facility holds equipment and formulations intended to facilitate precision dosage of cannabidiol (“CBD”) and cannabigerol (“CBG”) product formulations, including tinctures, gel caps, topical products and edibles. An article discussing the company reads, “In the spring of 2019, Hemptown USA acquired 4.5 million rare hemp seeds. These have been divided three ways — one third went to Kentucky, another third was planted in Colorado, and the final third (all CBG genetics) remained in Oregon. The seeds were planted in greenhouses to begin with, and in mid-summer, they were taken outdoors and planted on over 1,500 acres of land in the three states. . . . Based on its crop production efforts and the acquisition of the Kirkman Group production facility, Hemptown USA can fast track formulations, product development and subsequent distribution.”

To view the full article, visit http://cnw.fm/Af16B

About Hemptown USA

Hemptown USA is growing some of the finest high-cannabinoid hemp plants in the world. Following an impressive first-year yield, Hemptown USA is scaling up its operation to meet the ever-increasing global demand for cannabinoid products. With expanded farmland spanning three states and in-house extraction and processing facilities, Hemptown USA is now positioned to vertically integrate into the Consumer Packaged Goods sectors with top-quality-branded product lines for the consumer market. Hemptown USA’s vertically integrated business model is well positioned to capitalize on a global market expected to exceed $22 billion by 2020. For more information, visit the company’s website at www.HemptownUSA.com.

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/Disclaimer

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
[email protected]

HempWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000